The role of advanced lipid testing in clinical practice

Dean G Karalis1

  • 1Drexel University College of Medicine, Philadelphia, PA 19107, USA. dgk25@drexel.edu

Preventive Cardiology
|October 6, 2007
PubMed

Insights

Advanced cholesterol tests can supplement the Framingham risk score for better cardiovascular risk assessment. These tests are valuable for specific patient groups, including those with a family history of premature coronary heart disease.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Clinical Lipidology

Background:

  • The National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) guidelines utilize the Framingham risk score for cardiovascular risk assessment.
  • The Framingham risk score may underestimate the actual risk of coronary heart disease (CHD).
  • Emerging lipid risk factors have been identified that can be assessed using advanced cholesterol tests.

Purpose of the Study:

  • To review the role of advanced lipid testing in clinical practice.
  • To evaluate how emerging lipid risk factors can supplement existing cardiovascular risk assessment tools.
  • To identify patient populations that may benefit from advanced lipid testing.

Main Methods:

  • Review of current clinical guidelines and literature on cardiovascular risk assessment.
  • Analysis of the utility of advanced cholesterol tests in identifying emerging lipid risk factors.
  • Examination of the clinical application of advanced lipid testing in specific patient subgroups.

Main Results:

  • Advanced lipid testing can provide additional information beyond the Framingham risk score.
  • Emerging lipid risk factors measured by advanced tests may refine cardiovascular risk stratification.
  • These tests are not recommended for routine screening but are valuable in select populations.

Conclusions:

  • Advanced lipid testing can enhance cardiovascular risk assessment, particularly for individuals at intermediate risk or with specific risk factors.
  • Clinicians can use advanced lipid testing to better manage patients at risk for coronary heart disease.
  • The review highlights the supplementary role of advanced lipid testing in personalized cardiovascular risk management.

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...